Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.

Niflumic Acid

MSDS

CAS:4394-00-7

Molecular Formula:C13H9F3N2O2

Alias

More Information

Nifluril; Forenol; Landruma; Nifluminic Acid; Acido Niflumico; Acide Niflumique; 2-{[3-(Trifluoromethyl)Phenyl]Amino}Pyridine-3-Carboxylic Acid; 2-[3-(Trifluoromethyl)Anilino]Pyridine-3-Carboxylic Acid; 2-(3-(Trifluoromethyl)-Phenyl)Aminonicotinic Acid; 2-(3-Trifluoromethylanilino)Nicotinic Acid; 2-(3-(Trifluoromethyl)Anilino)Nicotinic Acid; 2-[3-(Trifluoromethyl)Anilino]Nicotinic Acid; 2-{[3-(Trifluoromethyl)Phenyl]Amino}Nicotinic Acid; 2-((3-(Trifluoromethyl)Phenyl)Amino)Nicotinic Acid; 3-Pyridinecarboxylic Acid, 2-[[3-(Trifluoromethyl)Phenyl]Amino]-; 2-(Alpha,Alpha,Alpha-Trifluoro-M-Toluidino)Nicotinic Acid; 2-(3-(Trifluoromethyl)Phenylamino)Nicotinic Acid; 2-[(3-Trifluoromethyl)Phenyl]Amino-3-Pyridine-Carboxylic Acid

Brief Introduction

Nifluoric acid is a drug used for joint and muscle pain. It belongs to non steroidal anti-inflammatory and analgesic drugs, and its curative effect is better than other anti-inflammatory and analgesic drugs. It can be used in elderly patients, acute and chronic arthritis, non joint inflammation, trauma and post-operative inflammation, bronchitis, pneumonia, acute superficial thrombophlebitis, etc.

Iodamide

MSDS

CAS:440-58-4

Molecular Formula:C12H11I3N2O4

Brief Introduction

Iodamide is a benzoic acid compound having iodo substituents at the 2-, 4- and 6-positions, an acetamido substituent at the 3-position and an acetamidomethyl substituent at the 5-position. It has a role as a radioopaque medium. It is a member of benzoic acids and an organoiodine compound.

Clemizole

MSDS

CAS:442-52-4

Molecular Formula:C19H20ClN3

Alias

More Information

Histakool; Clemizol; 1-(4-Chloro-Benzyl)-2-Pyrrolidin-1-Ylmethyl-1H-Benzoimidazole; 1-(P-Chlorobenzyl)-2-Pyrrolidylmethylenebenzimidazole; 1-(4-Chloro-Benzyl)-2-Pyrrolidinomethyl-1H-Benzimidazole; Histacur; 1-(4-Chlorobenzyl)-2-(Pyrrolidin-1-Ylmethyl)-1H-Benzimidazole; 1-(4-Chlor-Benzyl)-2-Pyrrolidinomethyl-1H-Benzimidazol; 1H-Benzimidazole,1-[(4-Chlorophenyl)Methyl]-2-(1-Pyrrolidinylmethyl); 1-[(4-Chlorophenyl)Methyl]-2-(Pyrrolidin-1-Ylmethyl)Benzimidazole; Clemizolum

Brief Introduction

Pyrrolidazole is also called 1 - [(4-chlorophenyl) methyl] - 2 - (pyrrolidine-1-ylmethyl) benzimidazole and krimidazole. It has antihistamine effect, moderate sedative effect and obvious antipruritic effect. The latest research shows that it has the effect of anti hepatitis C virus. This product can prolong the effective refractory period of atrial muscle, and it has been reported to treat atrial flutter. Side effects are rare.

Ethyl [(2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[5-Methyl-1-Propan-2-Yl-4-[(4-Propan-2-Yloxyphenyl)Methyl]Pyrazol-3-Yl]Oxyoxan-2-Yl]Methyl Carbonate

MSDS

CAS:442201-24-3

Molecular Formula:C26H38N2O9

Alias

More Information

Kgt-1681; Remogliflozin Etabonate; Unii-Tr0Qt6Qsul; Remogliflozin Etabonate (Usan/Inn); Gsk-189075; Tr0Qt6Qsul

Brief Introduction

Remogliflozin Etabonate is an orally available prodrug of remogliflozin, a benzylpyrazole glucoside-based inhibitor of renal sodium-glucose co-transporter subtype 2 (SGLT2) with antihyperglycemic activity. Upon administration and absorption, the inactive prodrug is converted to its active form remogliflozin and acts selectively on the sodium-glucose co-transporter subtype 2 (SGLT2).

Inquiry (

/ 10

)

Clear All